Jane Street
TYRA icon

Jane Street’s Tyra Biosciences TYRA Stock Holding History

Jane Street’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,169
Closed -$336K – 13179
2026
Q1 		$389K Buy
+10,169
New +$329K ﹤0.01% 8612
2025
Q4 		– Sell
-44,680
Closed -$625K – 12427
2025
Q3 		$625K Sell
44,680
-13,488
-23% -$154K ﹤0.01% 7362
2025
Q2 		$557K Buy
58,168
+23,355
+67% +$222K ﹤0.01% 6715
2025
Q1 		$324K Buy
+34,813
New +$450K ﹤0.01% 7674
2024
Q4 		– Sell
-31,003
Closed -$729K – 10630
2024
Q3 		$729K Sell
31,003
-9,995
-24% -$210K ﹤0.01% 6535
2024
Q2 		$656K Buy
+40,998
New +$706K ﹤0.01% 6575

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Jane Street's TYRA Position: Q2 2026 in Review

Jane Street sold out of Tyra Biosciences (TYRA) in Q2 2026, closing a stake of 10,169 shares — an estimated $336K sold.

Jane Street first reported a position in TYRA in Q2 2024 and held it in 6 quarters. The position peaked at $729K in Q3 2024. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Jane Street reported no remaining Tyra Biosciences position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 10,169 Tyra Biosciences shares in Q2 2026, an estimated $336K.
  • Jane Street first reported a position in Tyra Biosciences in Q2 2024 and held it in 6 quarters.
  • Jane Street's Tyra Biosciences position peaked at $729K in Q3 2024.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.